Interleukin-12 Inhibits Angiogenesis Induced by Human Tumor Cell Lines In Vivo
- 1 May 1996
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 106 (5), 1114-1118
- https://doi.org/10.1111/1523-1747.ep12340161
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Retinoids, Interferon α, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RARα mediates the antiangiogenic effect of retinoidsCancer Letters, 1995
- Report of a Meeting; Molecular Basis of Cancer TherapyJNCI Journal of the National Cancer Institute, 1994
- Antitumor Activity of Interleukin-12Clinical Immunology and Immunopathology, 1994
- Synergistic effect of retinoids and interferon α on tumor‐induced angiogenesis: Anti‐angiogenic effect on HPV‐harboring tumor‐cell linesInternational Journal of Cancer, 1994
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- Actions of TNF and INF-γ on Angiogenesis In VitroJournal of Investigative Dermatology, 1990
- Development of angiogenesis inhibitors for clinical applicationsTrends in Pharmacological Sciences, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Inhibition of tumour-induced angiogenesis by systemically administered protamine sulphateInternational Journal of Cancer, 1984
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971